About
Company Strategy
Group Structure
Board of directors
Management
Career
Contacts
Development
Drugs
Medical devices
Medical services
Biotech valuation
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Investor
Disclosure of information
News
En
RU
CN
Главная
News
News
News, press releases, events, publications
All categories
All categories
News
Press releases
Press about us
Portfolio
Portfolio
Histograft
Betuvax
Nextgen
Gemabank
Genetico
Biotechnology Developments
Genotarget
Reprobank
Vitacel
12.07.2023
Press releases
The HSCI Board of Directors approved a new dividend polic
04.07.2023
Press releases
Genetico’s experts speak about the prevention of monogenic diseases at the meeting of the Russian Society of Medical Genetics
30.06.2023
Press releases
HSCI is to pay dividends
19.06.2023
Press releases
Genetic embryo testing will reduce the costs of unsuccessful IVF cycles by 2 times
16.06.2023
Press releases
Betuvax-CoV-2 vaccine to undergo phase 3 clinical trial
15.06.2023
Press releases
The gene therapy drug developer opens a new laboratory at Medtech Technopark
09.06.2023
News
Russia’s genetic embryo testing market valued at $13.05 million
1
…
11
12
13
14
15
…
17
Up
About the Company
About
Company Strategy
Group Structure
Board of Directors
Management
Career
Contacts
Development Portfolio
Drugs
Medical Devices
Medical Services
Activity
Areas of activities
Research and development (R&D) stages
Ecosystem
Acceleration
Commercialization
Biotech Valuation
Investors
Disclosure of information
